tiprankstipranks
Immuron CEO to Unveil Advances at Melbourne Event
Company Announcements

Immuron CEO to Unveil Advances at Melbourne Event

Immuron Limited (AU:IMC) has released an update.

Pick the best stocks and maximize your portfolio:

Immuron Limited’s CEO Steven Lydeamore is set to present at Peak Asset Management’s Peak Sky High event in Melbourne, showcasing the company’s advancements in orally delivered targeted polyclonal antibodies for infectious diseases. The presentation will include information on their flagship product, Travelan®, which is designed to prevent travelers’ diarrhea and is available in various forms across Australia, Canada, and the U.S. The company’s proprietary technology enables the creation of treatments for a range of infectious diseases, leveraging hyper-immune bovine colostrum.

For further insights into AU:IMC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskImmuron Limited Director Acquires Unlisted Options
TipRanks Australian Auto-Generated NewsdeskImmuron Limited Director Increases Stake with New Options
TipRanks Australian Auto-Generated NewsdeskImmuron Limited Director Acquires 1,000,000 Options
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App